Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.

Anthem Biosciences Limited, an innovation-driven and technology-focused contract research, development, and manufacturing ...

Is the Anthem Biosciences Ltd profitable? For the year ended 2023, Anthem Biosciences Ltd had posted a profit of Rs 385.19 crore on a total income of Rs 1,056.92 crore. 6. Whic ...

Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...

Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...

The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment was finalized on ...

The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...

A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...

On the last 16 sessions grey market activities, the lowest GMP is Rs 0, while the highest GMP is Rs 157. So, if we go by the ...